Andrea M. Russo, MD, Chair
Dr. Russo, board certified in Cardiovascular Disease and Clinical Cardiac Electrophysiology, is Professor of Medicine at Cooper Medical School of Rowan University, Academic Chief of Division of Cardiology, Director of Electrophysiology and Arrhythmia Services, and Director of the Clinical Cardiac Electrophysiology Fellowship Program at Cooper University Hospital in Camden, New Jersey. Dr. Russo serves as Chair of the American Board of Internal Medicine (ABIM) Cardiovascular Disease Board and member of the ABIM Council. She previously served on the ABIM Cardiovascular Test Writing Committee and the American Board of Medical Specialties Continuing Board Certification Vision for the Future Commission.
She is past President of the Heart Rhythm Society (HRS), current member of the American Heart Association (AHA) Atrial Fibrillation Systems of Care Advisory Committee and member of the American College of Cardiology (ACC) Cardio-Obstetrics Council. She previously served on or chaired multiple HRS, ACC, or AHA committees, subcommittees or working groups. In addition, she has served as co-Chair or member on several guideline and consensus documents, as well as Appropriate Use criteria writing groups. She also serves on editorial boards for several peer reviewed journals and is a current Associate Editor for Circulation: Arrhythmia and Electrophysiology. She has served on steering committees, events committees, and data safety monitoring committees for several clinical trials. Her areas of research interest include implantable cardioverter defibrillators, atrial fibrillation therapies, sex differences in arrhythmias, and the role of digital health in arrhythmia management.
As of November 2022, Dr. Russo reported the following external relationships:
Funding for clinical trial expenses and staff, paid to Cooper University, from the following companies:
- Boston Scientific
- Kaestra
- MediLynx
- Medtronic
Service on data and safety monitoring boards for the following company, with honoraria:
- Biosense Webster Inc.
Service on a research-related steering committee for the following companies, without compensation:
- Bayer
- Medtronic
Research-related consulting for the following companies, with honoraria:
- Abbott
- Atricure
- Biosense Webster Inc.
- Medtronic
- PaceMate
Industry-supported continuing medical education supported by the following, with compensation for travel expenses and honoraria:
- Medtronic
- Sanofi
Work as an author or editor for the following companies, with compensation as listed:
- UpToDate®, receiving compensation as an editor for chapters related to implantable cardioverter defibrillator therapy.
Dr. Russo serves in significant roles with the following organization, receiving reimbursement or compensation as listed:
- Heart Rhythm Society, President, receiving reimbursement for travel expenses.
Craig Beam
Craig Beam is President of Petra ICS. Mr. Beam has overseen the development and management of a broad range of real estate with a focus on healthcare and institutional projects. Mr. Beam’s involvement in healthcare development includes the planning and development of hospital, medical office and ambulatory facilities. He is nationally recognized for his ability to lead assignments that are complex in program, finance and construction. He has over 30 years practicing nationally and internationally.
Mr. Beam started his career in real estate in 1977 as Chief Financial Officer of Concordia Development, a real estate development company based in Southern California. He then founded his own firm, Beam & Associates starting in 1983. At Beam had overall responsibility for the consulting, development, leasing and brokerage divisions of the firm. The firm was consistently ranked in the top 5 health care program and project management firms in the US. He merged this firm with Hammes Company in 1998 which created the largest healthcare project management firm in the United States. Mr. Beam has worked for major systems including Saint Joseph Health System of Orange, Ascension Health, MedStar and New York Presbyterian as well as academic centers such as Stanford, University of California San Francisco and Northwestern. Mr. Beam is a licensed California real estate broker and holds the professional designation of Counselor of Real Estate.
In addition to his real estate activities he has served on numerous boards including the advisory board to the Director of the National Institutes of Health, UniHealth, Pacificare and Martin Luther Hospital. He is past Chairman of the Board of the American Heart Association and is past Treasurer of the World Heart Federation.
Mr. Beam received a bachelor of arts degree in Business Administration from California State University in Fullerton, California
As of May 2023, Mr. Beam reported the following external relationships:
Mr. Beam serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- The American Heart Association, Vice Chair of Strategically Focused Health Tech Research, receiving reimbursement for travel expenses.
- Californians for Patient Care, Board of Directors, Member; Patient Safety Advocacy Group, Member, receiving reimbursement for travel expenses.
- The Center for Telemedicine, Member, receiving reimbursement for travel expenses.
- The Hospital Association of Southern California, AllHealth Board, Member, receiving honoraria.
- The InterAmerican Heart Foundation, Treasurer, receiving reimbursement for travel expenses.
Mr. Beam is Founder and Chief Financial Officer of Worksite Labs Inc.
Simbo Chiadika, MD
Dr. Chiadika is an Associate Professor of Medicine at McGovern Medical School/University of Texas (UT) Health Science Center, Houston. She is the Director of Cardiovascular services at the UT Health community clinic and serves as co-Director of Quality initiatives in Cardiology.
Dr. Chiadika is board certified in Internal Medicine and Cardiovascular Disease. Dr. Chiadika currently serves as a member of the American Board of Internal Medicine Cardiovascular Disease Board. She is a fellow of the American College of Cardiology and board certified in nuclear cardiology and echocardiography. She is a member of the Association of Black Cardiologists.
Dr. Chiadika is passionate about engaging and educating communities regarding cardiovascular disease. She is an active speaker for the American Heart Association (AHA) and serves as a member of the AHA Houston Health Equity Collective (formerly Greater Houston Coalition for Social Determinants of Health).
Dr. Chiadika earned a bachelor's degree in biochemistry at City University of New York and medical degree at Columbia University- School of Physicians & Surgeons in New York. She completed an internal medicine residency and nuclear cardiology fellowship at the New York Presbyterian Hospital – Columbia University and general cardiology fellowship at St. Luke's Roosevelt Hospital – Columbia University in New York.
As of May 2022, Dr. Chiadika reported the following ongoing external relationship:
- Dr. Chiadika provides educational lectures regarding amyloidosis to at-risk communities, receiving honoraria from Pfizer.
Suzanne A. Feigofsky, MD
Dr. Feigofsky is an electrophysiologist at the Iowa Heart Center in Carroll, Iowa. Previously she spent a decade in Orange County, CA in private practice. Dr. Feigofsky is board certified in Cardiology and Electrophysiology and currently serves as a member of the Heart Rhythm Society (HRS) communications committee and was recently appointed to the American College of Cardiology (ACC) Women in Cardiology Leadership Council. She also serves as a member of the American Board of Internal Medicine Cardiovascular Disease Specialty Board.
Dr. Feigofsky completed medical school at the University of Florida in Gainesville, FL and stayed on in Gainesville for internship, residency and fellowship training. Her clinical interests include syncope, postural orthostatic tachycardia syndrome POTS, as well as heart failure and cardio-oncology.
As of July 2022, Dr. Feigofsky reported the following external relationships:
Service on a research-related advisory board for the following company, with honoraria:
- Medtronic
Dr. Feigosky serves in significant roles with the following organization, receiving reimbursement or compensation as listed:
- The American College of Cardiology, Women in Cardiology Leadership Council Member, without compensation.
David E. Good, MD
Dr. Good is a general cardiologist at the Alaska Native Medical Center. He is also a United States Air Force Reserve Flight Surgeon, Commander of the 477 AMDF at Joint Base Elmendorf-Richardson.
Previously, he was an assistant professor in the Department of Internal Medicine at Louisiana State University in New Orleans, Louisiana and the Department of Cardiovascular Disease, in Lafayette, Louisiana. There he was involved in research, teaching and curriculum development.
Dr. Good completed his undergraduate degree at the University of Alabama in Birmingham and medical degree from the University of Alabama School of Medicine. His residency at Louisiana State University was in internal medicine/clinical investigator pathway, with research in the gene therapy department. His fellowship was in cardiovascular disease from Ochsner Clinic Foundation in New Orleans, Louisiana.
He is certified by the American Board of Internal Medicine in Internal Medicine, Cardiovascular Disease and Advanced Heart failure and Transplantation.
As of September 2021, Dr. Good reported the following ongoing external relationships:
Dr. Good discussed preliminary development of an application-based educational tool designed to teach cardiac anatomy.
John M. Herre, MD
Dr. Herre served on the faculty of the Medical College of Virginia from 1983 to 1985 and served on the faculty of the University of California, San Francisco, from 1985 to 1988 before moving to Norfolk, Virginia, where he started the Cardiac Electrophysiology program at Sentara Norfolk General Hospital. In 2006, Dr. Herre co-founded the Sentara Cardiovascular Research Institute and continues to serve as its Scientific Director. Dr. Herre has served on the Thoracic Organ and Membership and Professional Services Committees of the United Network of Organ Sharing. He is Chairman of the Board of Directors of LifeNet Health, a not-for-profit Organ Procurement Organization and leader in bio-implant technologies and cellular therapies. Dr Herre is a Professor of Medicine at Eastern Virginia Medical School (EVMS) and served as Chief, Division of Cardiology, from 2000 to 2010. He is Chair of the Institutional Review Board at EVMS and is an author of more than 100 publications in the areas of cardiac electrophysiology and heart failure. Dr Herre is a member of Sentara Cardiology Specialists and continues to care for patients with advanced heart failure, mechanical circulatory support and heart transplantation.
Dr. Herre's interest in advanced heart failure began with the founding of the Heart Transplant program at Sentara Norfolk General Hospital in 1989. He served as Program Director for the Heart Transplant Program from 2003 until 2017. He is certified by the American Board of Internal Medicine in Internal Medicine, Cardiology and Advanced Heart Failure/Transplant Cardiology and served on the Test Writing Committee for Advanced Heart Failure/Transplant Cardiology form 2011 until 2017. He is currently a member of the American Board of Internal Medicine Cardiovascular Disease Board.
Dr. John M. Herre received his undergraduate degree from Carnegie-Mellon University in 1973 and his Doctor of Medicine from Vanderbilt University in 1977. He completed training in Internal Medicine, Cardiology and Cardiac Electrophysiology at Baylor College of Medicine in 1983.
As of August 2022, Dr. Herre reported the following external relationships:
Funding for clinical trial expenses, staff and salary support, paid to Sentara Norfolk General Hospital, from the following companies:
- Abbott, for a study of hemodynamic-guided management of heart failure.
- Amedisys, for a new clinical trial.
- Boston Scientific, for a clinical trial of a subcutaneous implantable cardioverter-defibrillator in the management of heart failure.
- Duke Research Institute, for two new clinical trials.
- EBV Systems, for a study of the stimulation of the left ventricular endocardium for cardiac resynchronization therapy.
Service on data and safety monitoring boards for the following company, with honoraria:
- Medtronic, for a clinical trial of resynchronization after myocardial infarction.
Post-marketing clinical research funding for clinical trial expenses, staff and salary support, with funding provided to Sentara Norfolk General Hospital, from the following company:
- Boston Scientific, for a post-marketing study of the subcutaneous implantable cardioverter-defibrillator.
Dr. Herre serves in significant roles with the following organization, receiving reimbursement or compensation as listed:
- LifeNet Health, Board of Directors, Chair, receiving reimbursement for travel expenses and honoraria.
Yuli Kim, MD
Dr. Kim serves as the medical director of the Philadelphia Adult Congenital Heart Center, a joint program between the Children's Hospital of Philadelphia (CHOP) and Penn Medicine as well as the fellowship director for the ACHD fellowship program at the Hospital of the University of Pennsylvania. She is an Assistant Professor of Medicine at the Perelman School of Medicine at the University of Pennsylvania and board certified in Adult Congenital Heart Disease.
Dr. Kim completed her undergraduate degree at Georgetown University and medical degree from the University of Virginia. She was an Osler resident at the Johns Hopkins Hospital in Internal Medicine and went on to the Cleveland Clinic for Cardiovascular Medicine fellowship training. She completed a two-year fellowship in Adult Congenital Heart Disease at Boston Children's Hospital and the Brigham and Women's Hospital.
As of July 2022, Dr. Kim reported the following external relationships:
Dr. Kim serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- The Administrative Core Research Collaborative, Member, without compensation.
- The Adult Congenital Heart Association, Medical Advisory Board, Member, without compensation.
- The American Heart Association, Adult Congenital Heart Disease Young Hearts Subcommittee, Member, without compensation.
- The International Society of Adult Congenital Heart Disease, United States Representative, without compensation.
Rowlens M. Melduni, MD
Dr. Melduni is an Associate Professor of Medicine and faculty in the Department of Cardiovascular Medicine at Mayo Clinic School of Medicine, Rochester, Minnesota. Dr Melduni is the Director of the cardioversion unit at the Mayo Clinic Rochester. He is the founder and president and CEO of Clinicians of the World and serves on the American Board of Internal Medicine (ABIM) Cardiovascular Board. He is board certified in Internal Medicine, Cardiovascular Disease and Adult Comprehensive Echocardiography.
Dr. Melduni's research interests include the pathogenetic mechanism of atrial fibrillation, epidemiology and prognosis of atrial fibrillation and discovery of biomarkers of atrial fibrillation. He has authored numerous peer-reviewed publications, which have helped to improve our understanding of the mechanisms of atrial fibrillation, which has perplexed clinicians for quite some time. His work has recently received a major funding award from the National Institute of Health to examine the role of autoimmune mechanisms in the pathogenesis of atrial fibrillation. He was named a Rising Star Investigator by the American Society of Echocardiography in 2018.
Dr. Melduni received his medical degree from the University of Florida in Gainesville, Florida. He completed his internal medicine internship and residency at Boston University Medical Center and obtained his cardiology training at Albert Einstein University Hospital and went on to complete subspecialty fellowship in echocardiography at the Mayo Clinic Rochester. He received his master's degree in public health from the Harvard University School of Public Health in 2012.
As of May 2023, Dr. Melduni reported no external relationships.
Leslie Beth Sossoman
Leslie Beth (L.B.) Sossoman, DNP, ACNP-BC, CV-RN, CPHQ has been a cardiac nurse for more than 30 years. Dr. Sossoman serves as the Faculty Specialist for the AG-ACNP Program, a collaboration between Atrium Health and UNC Charlotte to prepare nurse practitioners for the complex needs of hospitalized patients. She holds an appointment as Associate Graduate Faculty at UNC Charlotte. She maintains a clinical practice in Advanced Heart Failure at Atrium Health Sanger Heart & Vascular Institute.
Dr. Sossoman is also certified as an Acute Care Nurse Practitioner and a Cardiac Vascular Nurse from the American Nurses Credentialing Center and as a Certified Professional in HealthCare Quality from the National Association of Healthcare Quality.
Dr. Sossoman completed her undergraduate studies at Presbyterian Hospital School of Nursing and Wingate University. She has a Master of Science in Nursing from the University of South Carolina and her Doctor of Nursing Practice from UNC Charlotte.
As of November 2022, Ms. Sossoman reported the following external relationships.
Ms. Sossoman serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- Metrolina Coalition of Nurse Practitioners, President, without compensation.
- North Carolina Nurses Association, Regional Liaison Person for the Metrolina Region of North Carolina, without compensation.